Genetic diversity of Xanthomonas citri subsp. citri in citrus orchards in northwest Paraná state, Brazil

Xanthomonas citri subsp. citri, which causes Asiatic citrus canker (ACC), is an important pathogen of citrus in Brazil and elsewhere. The genetic diversity of X. citri subsp. citri pathotype ‘A’ has not been studied in Brazil at a local scale (up to 300 km). Forty isolates were sampled from lesions of ACC on citrus in three orchards in Paraná state, Brazil. Twelve minisatellite markers were used to characterize the genetic diversity of the isolates. An Unweighted Paired Group Method of Arithmetic Averages tree was used for identifying unique multilocus haplotypes but there was no association between haplotypes and source locations. An analysis of molecular variance among populations showed that 98% of the variance was accounted for within the populations, and only 2% was accounted for among populations. Differences among populations was not significant (Φ=0.018, P=0.2). The relatively high, yet uniform, genetic diversity among isolates and low degree of spatial differentiation between populations of X. citri subsp. citri suggests that the populations in Paraná state have a common origin and strong historical epidemiological links

O cuidado em saúde mental pelos agentes comunitários de saúde: o que aprendem em seu cotidiano de trabalho?

Este trabalho visa descrever o conhecimento em saúde mental construído pelo agente comunitário de saúde, concomitante à produção de cuidado em saúde mental. Trata-se de pesquisa qualitativa, cujo referencial teórico é o Construcionismo Social. Os dados foram produzidos em grupos focais, analisados e elencados nas seguintes categorias temáticas: “A gente precisa orientar as famílias”, que agrupa os entidos relacionados à construção do cuidado às famílias que convivem com o sofrimento mental; “Só de você parar e ouvir...”, onde se descrevem os repertórios relacionados ao uso de tecnologias relacionais de cuidado; “Nós sabemos disso, porque nós andamos ali”, que delineia as estratégias para construção de saberes e, finalmente, a categoria que descreve os sentidos do medo do louco: “A gente tem medo daquilo que a gente vê”. Conclui-se que os conhecimentos construídos no cotidiano de trabalho dos agentes comunitários de saúde, quando refletidos e sistematizados, são potentes para a produção de práticas de cuidado condizentes com o paradigma psicossocial de atenção a pessoas e famílias em sofrimento mental

Produção orgânica de calêndula: um estudo de caso.

Apresenta-se caracterização do processo de produção agrícola orgânica de Calendula officinalis L. no Estado de Santa Catarina, evidenciando particularidades e discrepâncias frente aos modelos já descritos na literatura especializada, a partir de visitas a campo, observação participante e entrevistas com um produtor de plantas medicinais. Identificaram-se como principais particularidades a saúde na agricultura familiar, demonstrada pela prática da cultura orgânica, além do controle de pragas e manuseio da produção. Os principais problemas ou divergências evidenciados foram: características do solo; época de plantio da calêndula e suas etapas posteriores, como transplante e floração. Aspectos da colheita foram discrepantes quanto ao período do dia indicado para o procedimento, bem como a ausência de informações do produtor quanto à existência de outros incentivos governamentais ao setor agrícola. Recomenda-se aos extensionistas rurais e/ou instituições competentes que busquem orientar os produtores orgânicos de calêndula para promover a adequação das práticas de cultivo dessa espécie medicinal

Tyrosine-protein kinase Yes controls endothelial junctional plasticity and barrier integrity by regulating VE-cadherin phosphorylation and endocytosis

Vascular endothelial (VE)-cadherin in endothelial adherens junctions is an essential component of the vascular barrier, critical for tissue homeostasis and implicated in diseases such as cancer and retinopathies. Inhibitors of Src cytoplasmic tyrosine kinase have been applied to suppress VE-cadherin tyrosine phosphorylation and prevent excessive leakage, edema and high interstitial pressure. Here we show that the Src-related Yes tyrosine kinase, rather than Src, is localized at endothelial cell (EC) junctions where it becomes activated in a flow-dependent manner. EC-specific Yes1 deletion suppresses VE-cadherin phosphorylation and arrests VE-cadherin at EC junctions. This is accompanied by loss of EC collective migration and exaggerated agonist-induced macromolecular leakage. Overexpression of Yes1 causes ectopic VE-cadherin phosphorylation, while vascular leakage is unaffected. In contrast, in EC-specific Src deficiency, VE-cadherin internalization is maintained and leakage is suppressed. In conclusion, Yes-mediated phosphorylation regulates constitutive VE-cadherin turnover, thereby maintaining endothelial junction plasticity and vascular integrity

Trends and outcome of neoadjuvant treatment for rectal cancer: A retrospective analysis and critical assessment of a 10-year prospective national registry on behalf of the Spanish Rectal Cancer Project

Introduction: Preoperative treatment and adequate surgery increase local control in rectal cancer. However, modalities and indications for neoadjuvant treatment may be controversial. Aim of this study was to assess the trends of preoperative treatment and outcomes in patients with rectal cancer included in the Rectal Cancer Registry of the Spanish Associations of Surgeons. Method: This is a STROBE-compliant retrospective analysis of a prospective database. All patients operated on with curative intention included in the Rectal Cancer Registry were included. Analyses were performed to compare the use of neoadjuvant/adjuvant treatment in three timeframes: I)2006–2009; II)2010–2013; III)2014–2017. Survival analyses were run for 3-year survival in timeframes I-II. Results: Out of 14, 391 patients, 8871 (61.6%) received neoadjuvant treatment. Long-course chemo/radiotherapy was the most used approach (79.9%), followed by short-course radiotherapy ± chemotherapy (7.6%). The use of neoadjuvant treatment for cancer of the upper third (15-11 cm) increased over time (31.5%vs 34.5%vs 38.6%, p = 0.0018). The complete regression rate slightly increased over time (15.6% vs 16% vs 18.5%; p = 0.0093); the proportion of patients with involved circumferential resection margins (CRM) went down from 8.2% to 7.3%and 5.5% (p = 0.0004). Neoadjuvant treatment significantly decreased positive CRM in lower third tumors (OR 0.71, 0.59–0.87, Cochrane-Mantel-Haenszel P = 0.0008). Most ypN0 patients also received adjuvant therapy. In MR-defined stage III patients, preoperative treatment was associated with significantly longer local-recurrence-free survival (p < 0.0001), and cancer-specific survival (p < 0.0001). The survival benefit was smaller in upper third cancers. Conclusion: There was an increasing trend and a potential overuse of neoadjuvant treatment in cancer of the upper rectum. Most ypN0 patients received postoperative treatment. Involvement of CRM in lower third tumors was reduced after neoadjuvant treatment. Stage III and MRcN + benefited the most

7th Drug hypersensitivity meeting: part two

No abstract availabl

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362